Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · IEX Real-Time Price · USD
1.800
+0.030 (1.69%)
At close: Jun 25, 2024, 4:00 PM
1.760
-0.040 (-2.22%)
Pre-market: Jun 26, 2024, 8:51 AM EDT
Entero Therapeutics Statistics
Total Valuation
ENTO has a market cap or net worth of $4.95 million. The enterprise value is $8.47 million.
Market Cap | 4.95M |
Enterprise Value | 8.47M |
Important Dates
The next estimated earnings date is Tuesday, August 20, 2024, before market open.
Earnings Date | Aug 20, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ENTO has 2.75 million shares outstanding. The number of shares has increased by 12,625.67% in one year.
Shares Outstanding | 2.75M |
Shares Change (YoY) | +12,625.67% |
Shares Change (QoQ) | +4,214.50% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.31 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.21, with a Debt / Equity ratio of 0.43.
Current Ratio | 1.21 |
Quick Ratio | n/a |
Debt / Equity | 0.43 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -262.77 |
Financial Efficiency
Return on equity (ROE) is -107.60% and return on invested capital (ROIC) is -90.36%.
Return on Equity (ROE) | -107.60% |
Return on Assets (ROA) | -23.80% |
Return on Capital (ROIC) | -90.36% |
Revenue Per Employee | n/a |
Profits Per Employee | -$715,952 |
Employee Count | 9 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -14.86M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.67% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | -94.67% |
50-Day Moving Average | 2.62 |
200-Day Moving Average | 4.79 |
Relative Strength Index (RSI) | 29.38 |
Average Volume (20 Days) | 32,474 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -20.93M |
Pretax Income | -21.02M |
Net Income | -6.44M |
EBITDA | -20.90M |
EBIT | -20.94M |
Earnings Per Share (EPS) | -$31.10 |
Balance Sheet
The company has $3.46 million in cash and $6.98 million in debt, giving a net cash position of -$3.52 million or -$1.28 per share.
Cash & Cash Equivalents | 3.46M |
Total Debt | 6.98M |
Net Cash | -3.52M |
Net Cash Per Share | -$1.28 |
Equity / Book Value | 16.18M |
Book Value Per Share | 5.88 |
Working Capital | 1.32M |
Cash Flow
Operating Cash Flow | -13.28M |
Capital Expenditures | n/a |
Free Cash Flow | -13.28M |
FCF Per Share | -$7.54 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ENTO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -12,625.67% |
Shareholder Yield | -12,625.67% |
Earnings Yield | -130.17% |
FCF Yield | -268.26% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |